Skip to main content
. 2023 Apr 11;2023(4):CD013873. doi: 10.1002/14651858.CD013873.pub2

2.6. Analysis.

2.6

Comparison 2: High‐ versus standard‐dose strategies for prevention of apnea, Outcome 6: Bronchopulmonary dysplasia/chronic lung disease at 36 weeks' postmenstrual age